Trabecular bone deterioration in col9a1+/- mice associated with enlarged osteoclasts adhered to collagen IX-deficient bone

Journal of Bone and Mineral Research

Volumn 23, Issue 6, 2008, Pages 837-849

  Chiachien, Jake Wang ^a,b   Iida, Keisuke ^a   Egusa, Hiroshi ^a,c   Hokugo, Akishige ^a   Jewett, Anahid ^a   Nishimura, Ichiro ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b Engineering IV   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CT bone morphometry; Collagen IX; Osteoclast; Osteoporosis; Rodent

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 9; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ARTICLE; BONE DESTRUCTION; BONE DEVELOPMENT; BONE MATRIX; CELL STRUCTURE; COL9A1 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; KYPHOSIS; LUMBAR SPINE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; SPLEEN CELL; STROMA CELL; TIBIA; TRABECULAR BONE; WEIGHT REDUCTION;

AGING; ANIMALS; BODY WEIGHT; BONE DISEASES; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE IX; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; OSTEOCLASTS; PHENOTYPE;

EID: 44449135005     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080214     Document Type: Article

References (56)

1. Olsen BR 1997 Collagen IX. Int J Biochem Cell Biol 29:555-558.
2. Eyre DR, Wu JJ, Fernandes RJ, Pietka TA, Weis MA 2002 Recent developments in cartilage research: Matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans 30:893-899.
3. Shaw LM, Olsen BR 1991 FACIT collagens: Diverse molecular bridges in extracellular matrices. Trends Biochem Sci 16:191-194.
4. Vasios G, Nishimura I, Konomi H, van der Rest M, Ninomiya Y, Olsen BR 1988 Cartilage type IX collagen-proteoglycan contains a large amino-terminal globular domain encoded by multiple exons. J Biol Chem 263:2324-2329.
5. Nishimura I, Muragaki Y, Olsen BR 1989 Tissue-specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J Biol Chem 264:20033-20041.
6. Muragaki Y, Nishimura I, Henney A, Ninomiya Y, Olsen BR 1990 The alpha 1 (IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA. Proc Natl Acad Sci USA 87:2400-2404.
7. Swiderski RE, Solursh M 1992 Localization of type II collagen, long form alpha 1(IX) collagen, and short form alpha 1(IX) collagen transcripts in the developing chick notochord and axial skeleton. Dev Dyn 194:118-127.
8. Swiderski RE, Solursh M 1992 Differential co-expression of long and short form type IX collagen transcripts during avian limb chondrogenesis in ovo. Development 115:169-179.
9. Perala M, Savontaus M, Metsaranta M, Vuorio E 1997 Developmental regulation of mRNA species for types II, IX and XI collagens during mouse embryogenesis. Biochem J 324:209-216.
10. Fitch JM, Gordon MK, Gibney EP, Linsenmayer TF 1995 Analysis of transcriptional isoforms of collagen types IX, II, and I in the developing avian cornea by competitive polymerase chain reaction. Dev Dyn 202:42-53.
11. Nakata K, Ono K, Miyazaki J, Olsen BR, Muragaki Y, Adachi E, Yamamura K, Kimura T 1993 Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing alpha 1(IX) collagen chains with a central deletion. Proc Natl Acad Sci USA 90:2870-2874.
12. Fassler R, Schnegelsberg PN, Dausman J, Shinya T, Muragaki Y, McCarthy MT, Olsen BR, Jaenisch R 1994 Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA 91:5070-5074.
13. Hu K, Xu L, Cao L, Flahiff CM, Brussiau J, Ho K, Setton LA, Youn I, Guilak F, Olsen BR, Li Y 2006 Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. Arthritis Rheum 54:2891-2900.
14. Kimura T, Nakata K, Tsumaki N, Miyamoto S, Matsui Y, Ebara S, Ochi T 1996 Progressive degeneration of articular cartilage and intervertebral discs. An experimental study in transgenic mice bearing a type IX collagen mutation. Int Orthop 20:177-181.
15. Suzuki N, Asamura K, Kikuchi Y, Takumi Y, Abe S, Imamura Y, Hayashi T, Aszodi A, Fassler R, Usami S 2005 Type IX collagen knock-out mouse shows progressive hearing loss. Neurosci Res 51:293-298.
16. Asamura K, Abe S, Imamura Y, Aszodi A, Suzuki N, Hashimoto S, Takumi Y, Hayashi T, Fassler R, Nakamura Y, Usami S 2005 Type IX collagen is crucial for normal hearing. Neuroscience 132:493-500.
17. Ting K, Petropulos LA, Iwatsuki M, Nishimura I 1993 Altered cartilage phenotype expressed during intramembranous bone formation. J Bone Miner Res 8:1377-1387.
18. Ting K, Ramachandran H, Chung KS, Shah-Hosseini N, Olsen BR, Nishimura I 1999 A short isoform of Col9a1 supports alveolar bone repair. Am J Pathol 155:1993-1999.
19. Iida K, Nishimura I 2002 Gene expression profiling by DNA microarray technology. Crit Rev Oral Biol Med 13:35-50.
20. Egusa H, Schweizer FE, Wang CC, Matsuka Y, Nishimura I 2005 Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing. J Biol Chem 280:23691-23697.
21. Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H 2004 Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6) J Bone Miner Res 19:1128-1136.
22. Xu J, Feng HT, Wang C, Yip KHM, Pavlos N, Papadimitriou JM, Wood D, Zheng MH 2003 Effects of bafilomycin A1: An inhibitor of vacuolar H (p)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts. J Cell Biochem 88:1256-1264.
23. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
24. Deyama Y, Takeyama S, Koshikawa M, Shirai Y, Yoshimura Y, Nishikata M, Suzuki K, Matsumoto A 2000 Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells. Biochem Biophys Res Commun 274:249-254.
25. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA 2004 PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235-244.
26. Reddy SV 2004 Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 14:255-270.
27. Teitelbaum SL, Ross FP 2003 Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
28. Wallace JM, Rajachar RM, Allen MR, Bloomfield SA, Robey PG, Young MF, Kohn DH 2007 Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone 40:1120-1127.
29. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML 2007 Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22:1197-1207.
30. Asahina I, Sampath TK, Nishimura I, Hauschka PV 1993 Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol 123:921-933.
31. Hagg R, Hedbom E, Mollers U, Aszodi A, Fassler R, Bruckner P 1997 Absence of the alpha1(IX) chain leads to a functional knock-out of the entire collagen IX protein in mice. J Biol Chem 272:20650-20654.
32. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY 2006 Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648-1656.
33. Takayanagi H, Sato K, Takaoka A, Taniguchi T 2005 Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181-193.
34. Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon LY, Halloran BP 2005 Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res 20:30-40.
35. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M 1989 The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 109:1817-1826.
36. Sato M, Sardana MK, Crasser WA, Garsky VM, Murray JM, Gould RJ 1990 Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713-1723.
37. Horton MA, Taylor ML, Arnett TR, Helfrich MH 1991 Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195:368-375.
38. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M 1993 Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginylglycyl-aspartyl" (RGD)-containing protein. Endocrinology 132:1411-1413.
39. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL 1997 A peptido-mimetric antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99:2284-2292.
40. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL 2000 Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440.
41. Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV 2005 Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res 20:2116-2123.
42. Kapyla J, Jaalinoja J, Tulla M, Ylostalo J, Nissinen L, Viitasalo T, Vehvilainen P, Marjomaki V, Nykvist P, Saamanen AM, Farndale RW, Birk DE, Ala-Kokko L, Heino J 2004 The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix. J Biol Chem 279:51677-51687.
43. Castano H, O'Rear EA, McFetridge PS, Sikavitsas VI 2004 Polypyrrole thin films formed by admicellar polymerization support the osteogenic differentiation of mesenchymal stem cells. Macromol Biosci 4:785-794.
44. Dalby MJ, Riehle MO, Sutherland DS, Agheli H, Curtis AS 2005 Morphological and microarray analysis of human fibroblasts cultured on nanocolumns produced by colloidal lithography. Eur Cell Mater 9:1-8.
45. Teixeira AI, McKie GA, Foley JD, Bertics PJ, Nealey PF, Murphy CJ 2006 The effect of environmental factors on the response of human corneal epithelial cells to nanoscale substrate topography. Biomaterials 27:3945-3954.
46. Turner AM, Dowell N, Turner SW, Kam L, Isaacson M, Turner JN, Craighead HG, Shain W 2000 Attachment of astroglial cells to microfabricated pillar arrays of different geometries. J Biomed Mater Res 51:430-441.
47. Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS 2000 Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18:713-720.
48. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ 2001 Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16:1195-1206.
49. Bouxsein ML, Uchiyama T, Rosen CJ, Shultz KL, Donahue LR, Turner CH, Sen S, Churchill GA, Muller R, Beamer WG 2004 Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice. J Bone Miner Res 19:587-599.
50. Koller DL, Schriefer J, Sun Q, Shultz KL, Donahue LR, Rosen CJ, Foroud T, Beamer WG, Turner CH 2003 Genetic effects for femoral biomechanics, structure, and density in C57BL/6J and C3H/HeJ inbred mouse strains. J Bone Miner Res 18:1758-1765.
51. Briggs MD, Chapman KL 2002 Pseudoachondroplasia and multiple epiphyseal dysplasia: Mutation review, molecular interactions, and genotype to phenotype correlations. Hum Mutat 19:465-478.
52. Annunen S, Paassilta P, Lohiniva J, Perala M, Pihlajamaa T, Karppinen J, Tervonen O, Kroger H, Lahde S, Vanharanta H, Ryhanen L, Goring HH, Ott J, Prockop DJ, Ala-Kokko L 1999 An allele of COL9A2 associated with intervertebral disc disease. Science 285:409-412.
53. Karppinen J, Paakko E, Paassilta P, Lohiniva J, Kurunlahti M, Tervonen O, Nieminen P, Goring HH, Malmivaara A, Vanharanta H, Ala-Kokko L 2003 Radiologic phenotypes in lumbar MR imaging for a gene defect in the COL9A3 gene of type IX collagen. Radiology 227:143-148.
54. Solovieva S, Lohiniva J, Leino-Arjas P, Raininko R, Luoma K, Ala-Kokko L, Riihimaki H 2002 COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: Evidence of gene-environment interaction. Spine 27:2691-2696.
55. Xi YM, Hu YG, Lu ZH, Zheng HJ, Chen Y, Qi Z 2004 Gene expression of collagen types IX and X in the lumbar disc. Chin J Traumatol 7:76-80.
56. Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ 2004 Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci 45:1041-1046.